FDA issues guidance on submission of pharmacogenomic data
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct Lifecycle